Nonalcoholic Steatohepatitis Score is an Independent Predictor of Right Ventricular Dysfunction in Patients with Nonalcoholic Fatty Liver Disease

Cardiovascular Therapeutics

Volumn 33, Issue 5, 2015, Pages 294-299

  Sunbul, Murat ^a   Kivrak, Tarik ^b   Durmus, Erdal ^c   Akin, Hakan ^a   Aydin, Yucel ^a   Ergelen, Rabia ^a   Yilmaz, Yusuf ^a   Agirbasli, Mehmet ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Sivas Numune Hospital   (Turkey)

^c MERSIN STATE HOSPITAL   (Turkey)

Author keywords

Nonalcoholic fatty liver disease; Right ventricular function; Speckle tracking echocardiography

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLOBAL LONGITUDINAL STRAIN; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE SIZE; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; NONALCOHOLIC STEATOHEPATITIS SCORE; PREDICTION; PRIORITY JOURNAL; RIGHT ATRIAL AREA; RIGHT VENTRICULAR MAXIMAL SYSTOLIC MYOCARDIAL VELOCITY; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; TRICUSPID ANNULAR PLANE SYSTOLIC EXCURSION; TWO DIMENSIONAL SPECKLE TRACKING ECHOCARDIOGRAPHY; BLOOD ANALYSIS; COMPLICATION; ECHOCARDIOGRAPHY; FIBROSIS; HEMODYNAMICS; LIVER; PATHOLOGY; REGRESSION ANALYSIS;

ADULT; BLOOD CHEMICAL ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; FIBROSIS; HEMODYNAMICS; HUMANS; LIVER; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; REGRESSION ANALYSIS; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84941193870     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/1755-5922.12145     Document Type: Article

References (31)

1. Bhala N, Jouness RI, Bugianesi E. Epidemiology and natural history of patients with NAFLD. Curr Pharm Des 2013;19:5169e76.
2. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-1419.
3. Marchesini G, Brizi M, Bianchi G, etal. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001;50:1844-1850.
4. Adams LA, Lymp J, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P. The natural history of nonalcoholic fatty liver disease: a population based cohort study. Gastroenterology 2005;129:113-121.
5. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010;363:1341-1350.
6. Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 2004;40:46-54.
7. Villanova N, Moscatiello S, Ramilli S, etal. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005;42:473-480.
8. Targher G, Bertolini L, Padovani R, Zenari L, Zoppini G, Falezza G. Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation. Diabetes Care 2004;27:2498-2500.
9. Yilmaz Y, Kurt R, Gurdal A, etal. Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease. Atherosclerosis 2011;217:125-129.
10. Sunbul M, Agirbasli M, Durmus E, etal. Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness. Atherosclerosis 2014;237:490-493.
11. Bonapace S, Perseghin G, Molon G, etal. Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. Diabetes Care 2012;35:389-395.
12. Gianotti G, Cenni A, Bianchi G, Masetti M, Zappoli P, Muscari A, Zoli M. Pianoro Study Group. Diastolic dysfunction and cardiovascular risk in old subjects: possible association with NAFLD? Arch Gerontol Geriatr 2014;58:188-195.
13. Sunbul M, Durmus E, Kivrak T, etal. Left ventricular strain and strain rate by two-dimensional speckle tracking echocardiography in patients with subclinical hypothyroidism. Eur Rev Med Pharmacol Sci 2013;17:3323-3328.
14. Cincin A, Sunbul M, Kivrak T, etal. Evaluation of cardiac function by two-dimensional speckle tracking echocardiography in ulcerative colitis patients. Dig Dis Sci 2014;59:3004-3011.
15. Sunbul M, Bozbay M, Mammadov C, etal. Effect of vitamin D deficiency and supplementation on myocardial deformation parameters and epicardial fat thickness in patients free of cardiovascular risk. Int J Cardiovasc Imaging 2015;31:765-772.
16. Durmus E, Sunbul M, Tigen K, etal. Right ventricular and atrial functions in systemic sclerosis patients without pulmonary hypertension: Speckle-tracking echocardiographic study. Herz 2015;40:709-715.
17. Cincin A, Tigen K, Karaahmet T, etal. Right ventricular function in hypertrophic cardiomyopathy: a speckle tracking echocardiography study. Anatol J Cardiol 2015;15:536-541.
18. Baktir AO, Şarli B, Altekin RE, etal. Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography. Anadolu Kardiyol Derg 2015;15:137-142.
19. Kleiner DE, Brunt EM, Van Natta M, etal., Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-1321.
20. Cheitlin MD, Armstrong WF, Aurigemma GP, etal.; ACC; AHA; ASE. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Soc Echocardiogr 2003;16:1091-1110.
21. Leung DY, Ng AC. Emerging clinical role of strain imaging in echocardiography. Heart Lung Circ 2010;19:161-174.
22. Blessberger H, Binder T. Two-dimensional speckle tracking echocardiography: clinicalapplications. Heart 2010;96:2032-2040.
23. Demidenko E. Sample size determination for logistic regression revisited. Stat Med 2007;26:3385-3397.
24. Demidenko E. Sample size and optimal design for logistic regression with binary interaction. Stat Med 2008;27:36-46.
25. Meris A, Faletra F, Conca C, etal. Timing and magnitude of regional right ventricular function: a speckle tracking-derived strain study of normal subjects and patients with right ventricular dysfunction. J Am Soc Echocardiogr 2010;23:823-831.
26. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group.The metabolic syndrome - a new worldwide definition. Lancet 2005;366:1059-1062.
27. Karakurt O, Oztekin S, Yazihan N, Akdemir R. Impairedrightventricular functions in metabolic syndrome patients with preserved left ventricular ejection fraction. Turk Kardiyol Dern Ars 2011;39:549-556.
28. Marchesini G, Bugianesi E, Forlani G, etal. Nonalcoholic fatty liver disease, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37:917-923.
29. Soderberg C, Stal P, Askling J, Glaumann H, Lindberg G, Marmur J, Hultcrantz R. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 2010;51:595-602.
30. Chinali M, Devereux RB, Howard BV, etal. Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study). Am J Cardiol 2004;93:40-44.
31. Sunbul M, Kepez A, Kivrak T, Eroglu E, Ozben B, Yildizeli B, Mutlu B. Right ventricular longitudinal deformation parameters and exercise capacity: Prognosis of patients with chronic thromboembolic pulmonary hypertension. Herz 2014;39:470-475.